83 related articles for article (PubMed ID: 8016370)
1. [Preparation of mutant enzymes by means of refolding of polypeptide forming inclusion bodies and secretory expression system].
Nishiyama M; Beppu T
Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1366-72. PubMed ID: 8016370
[No Abstract] [Full Text] [Related]
2. Protein engineering of the milk-clotting aspartic proteinases.
Aikawa J; Nishiyama M; Beppu T
Scand J Clin Lab Invest Suppl; 1992; 210():51-8. PubMed ID: 1455180
[TBL] [Abstract][Full Text] [Related]
3. Oxidative refolding of recombinant prochymosin.
Wei C; Tang B; Zhang Y; Yang K
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):345-51. PubMed ID: 10229691
[TBL] [Abstract][Full Text] [Related]
4. Modification of milk-clotting aspartic proteinases by recombinant DNA techniques.
Beppu T
Ann N Y Acad Sci; 1990; 613():14-25. PubMed ID: 1963762
[No Abstract] [Full Text] [Related]
5. Molecular cloning and expression in yeast of caprine prochymosin.
Vega-Hernández MC; Gómez-Coello A; Villar J; Claverie-Martín F
J Biotechnol; 2004 Oct; 114(1-2):69-79. PubMed ID: 15464600
[TBL] [Abstract][Full Text] [Related]
6. Expression of a synthetic copy of the bovine chymosin gene in Aspergillus awamori from constitutive and pH-regulated promoters and secretion using two different pre-pro sequences.
Cardoza RE; Gutiérrez S; Ortega N; Colina A; Casqueiro J; Martín JF
Biotechnol Bioeng; 2003 Aug; 83(3):249-59. PubMed ID: 12783481
[TBL] [Abstract][Full Text] [Related]
7. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
8. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding.
Hung CC; Chiou SH
Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823
[TBL] [Abstract][Full Text] [Related]
9. Protein engineering of surface loops: preliminary X-ray analysis of the CHY155-165RHI mutant.
Dhanaraj RR; Pitts JE; Nugent P; Orprayoon P; Cooper JB; Blundell TL; Uusitalo J; Penttilä M
Adv Exp Med Biol; 1995; 362():95-9. PubMed ID: 8540386
[No Abstract] [Full Text] [Related]
10. Studies on the binding of alpha-crystallin to recombinant prochymosins and chymosin.
Chitpinityol S; Goode D; Crabbe MJ
Mol Vis; 1998 Jan; 4():1. PubMed ID: 9485484
[TBL] [Abstract][Full Text] [Related]
11. Refolding and purification of the human secreted group IID phospholipase A2 expressed as inclusion bodies in Escherichia coli.
Fonseca RG; Ferreira TL; Ward RJ
Protein Expr Purif; 2009 Oct; 67(2):82-7. PubMed ID: 19376232
[TBL] [Abstract][Full Text] [Related]
12. Role of the amino-terminal amino acid sequences determining the in vitro refolding process of prochymosin polypeptide.
Yonezawa M; Suzuki J; Nishiyama M; Horinouchi S; Beppu T
J Biotechnol; 1993 Mar; 28(1):85-97. PubMed ID: 7763527
[TBL] [Abstract][Full Text] [Related]
13. Fusion tags and chaperone co-expression modulate both the solubility and the inclusion body features of the recombinant CLIPB14 serine protease.
Schrödel A; Volz J; de Marco A
J Biotechnol; 2005 Oct; 120(1):2-10. PubMed ID: 16023240
[TBL] [Abstract][Full Text] [Related]
14. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
Misawa S; Kumagai I
Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
[TBL] [Abstract][Full Text] [Related]
15. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
16. In vitro refolding of carboxypeptidase T precursor from Thermoactinomyces vulgaris obtained in Escherichia coli as cytoplasmic inclusion bodies.
Trachuk L; Letarov A; Kudelina IA; Yusupova MP; Chestukhina GG
Protein Expr Purif; 2005 Mar; 40(1):51-9. PubMed ID: 15721771
[TBL] [Abstract][Full Text] [Related]
17. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
18. Direct refolding of inclusion bodies using reversed micelles.
Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
[TBL] [Abstract][Full Text] [Related]
19. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
20. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
